InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Chicoine, Daniel. Officer active across 2 companies, notably Crescita Therapeutics Inc.. Cumulatively, 12 reports have been published. Split: 9 buys · 0 sell. Total volume traded: €885k. History available since 3 June 2026. The latest transaction was disclosed on 15 June 2026 (36 - Conversion or exchange). Regulator: SEDI. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Daniel Chicoine is a declarant linked to Crescita Therapeutics Inc. and NeuPath Health Inc., where he is identified as 4 - Director of Issuer, 5 - Senior Officer of Issuer for the first company and 4 - Director of Issuer for the second. The 12 filings on record, all within the sampled set, concern acquisitions, with 885472 EUR of buys and 0 EUR of sells between 2026-06-08 and 2026-06-15, and the largest published filings relate to Crescita Therapeutics Inc.